Stryker Corp (SYK)
330.54
-0.32
(-0.10%)
USD |
NYSE |
May 10, 16:00
330.54
0.00 (0.00%)
After-Hours: 20:00
Stryker Profit Margin (Quarterly): 15.03% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 15.03% |
December 31, 2023 | 19.66% |
September 30, 2023 | 14.10% |
June 30, 2023 | 14.77% |
March 31, 2023 | 12.39% |
December 31, 2022 | 10.82% |
September 30, 2022 | 18.22% |
June 30, 2022 | 14.60% |
March 31, 2022 | 7.56% |
December 31, 2021 | 14.08% |
September 30, 2021 | 10.53% |
June 30, 2021 | 13.79% |
March 31, 2021 | 7.64% |
December 31, 2020 | 13.33% |
September 30, 2020 | 16.62% |
June 30, 2020 | -3.00% |
March 31, 2020 | 13.74% |
December 31, 2019 | 17.55% |
September 30, 2019 | 12.99% |
June 30, 2019 | 13.15% |
March 31, 2019 | 11.72% |
December 31, 2018 | 54.48% |
September 30, 2018 | 18.20% |
June 30, 2018 | 13.61% |
March 31, 2018 | 13.67% |
Date | Value |
---|---|
December 31, 2017 | -7.17% |
September 30, 2017 | 14.44% |
June 30, 2017 | 12.98% |
March 31, 2017 | 15.03% |
December 31, 2016 | 16.15% |
September 30, 2016 | 12.53% |
June 30, 2016 | 13.38% |
March 31, 2016 | 16.11% |
December 31, 2015 | 19.23% |
September 30, 2015 | 12.44% |
June 30, 2015 | 16.12% |
March 31, 2015 | 9.42% |
December 31, 2014 | 9.93% |
September 30, 2014 | 2.39% |
June 30, 2014 | 5.42% |
March 31, 2014 | 3.04% |
December 31, 2013 | 15.64% |
September 30, 2013 | 4.79% |
June 30, 2013 | 9.63% |
March 31, 2013 | 13.88% |
December 31, 2012 | 11.55% |
September 30, 2012 | 17.20% |
June 30, 2012 | 15.43% |
March 31, 2012 | 16.20% |
December 31, 2011 | 18.10% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.00%
Minimum
Jun 2020
19.66%
Maximum
Dec 2023
12.88%
Average
13.76%
Median
Profit Margin (Quarterly) Benchmarks
Boston Scientific Corp | 12.76% |
Haemonetics Corp | 9.29% |
Abbott Laboratories | 12.29% |
Zimmer Biomet Holdings Inc | 9.13% |
ResMed Inc | 25.10% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 18.69% |
Return on Assets | 8.77% |
Return on Invested Capital | 10.88% |
Gross Profit Margin (Quarterly) | 63.57% |
Operating Margin (Quarterly) | 18.54% |
Return on Net Operating Assets | 10.80% |